Drug Profile
Ciclosporin ocular implant
Alternative Names: Cyclosporine ocular implant; LUMITECT; LX 201Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator National Institutes of Health (USA)
- Developer Lux Biosciences
- Class Anti-inflammatories; Antineoplastics; Antipsoriatics; Antirheumatics; Ciclosporins; Eye disorder therapies; Heart failure therapies; Neuroprotectants
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Transplant rejection
Most Recent Events
- 07 Feb 2013 Discontinued - Phase-III for Transplant rejection in Germany (Intraocular)
- 07 Feb 2013 Discontinued - Phase-III for Transplant rejection in India (Intraocular)
- 07 Feb 2013 Discontinued - Phase-III for Transplant rejection in USA (Intraocular)